国际皮肤性病学杂志    0  (): 361-363   ISSN: 2096-5540  CN: 32-1880/R   血管新生的机制及在皮肤肿瘤和银屑病中的作用 王红梅, 刘晓明 大连医科大学附属第一医院皮肤科 116011 收稿日期 2005-03-22  修回日期 null  网络版发布日期 null 参考文献  [1] Longo R, Sarmiento R, Fanelli M, et al. Anti-angiogenic therapy:ratio nale, challenges and clinical studies. Angiogenesis., 2002, 5:237. [2] Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1996, 86:353-364. [3] Proniewska-Skretek E, Mariak Z. Tumor angiogensis in uveal melanoma. Role of vascular endothelial growth factor (VEGF). Klin Oczna, 2004, 106:682-685. [4] Folkman J, D'Amore PA. Blood vessel formation:what is its molec ular basis? Cell, 1996, 87:1153-1155. [5] Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A, 2002, 99:11205. [6] Sledge GW Jr, Miller KD. Angiogenesis and antiangiogenic therapy. Curr Probl Cancer, 2002, 26:1-60. [7] Dixelius J, Cross M, Matsumoto T, et al. Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res,2002, 62:1944-1947. [8] Folkman J. Antiangio genic activity of a matrix protein. Cancer Biol Ther, 2003, 2:53-54. [9] Streit M, Detmar M. Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene, 2003, 22:3172-3179. [10] Lin P, Buxton JA, Acheson A, et al. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.Proc Natl Acad Sci U S A, 1998, 95:8829-8834. [11] Detmar M, Velasco P, Richard L, et al. Expression of vascular en dothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol, 2000, 156:159-167. [12] Hawighorst T, Velasco P, Streit M, et al. Thrombospondin-2 plays aprotective role in multistep carcinogenesis:a novel host anti-tumor defense mechanism. EMBO J, 2001, 20:2631-2640. [13] Strieth S, Hartschuh W, Pilz L, et al. Angiogenic switch occurs late in squamous cell carcinomas of human skin. Br J Cancer, 2000, 82:591-600. [14] Bhushan M, Young HS, Brenchley PE, et al. Recent advances in cutaneous angiogenesis. Br J Dermatol, 2002, 147:418-425. [15] Brown LF, Dezube BJ, Tognazzi K, et al. Expression of Tie1, Tie2,and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol, 2000, 156:2179-2183. [16] Velasco P, Lange-Asschenfeldt B. Dermatological aspects of angiogenesis. Br J Dermatol, 2002, 147:841-852. [17] Albini A, Marchisone C, Del Grosso F, et al. Inhibition of angio genesis and vascular tumor growth by interferon-producing cells:A gene therapy approach. Am J Pathol, 2000, 156:1381-1393. [18] Hem S, Allen MH, Sousa AR, et al. Immunohistochemical evalua tion of psoriatic plaques following selective photothermolysis of the superficial capillaries. Br J Dermatol, 2001, 145:45-53. [19] Smyth AP, Rook SL, Detmar M, et al. Antisense oligonucleotides inhibit vascular endothelial growth factor/vascular permeability factor expression in normal human epidermal keratinocytes. J Invest Dermatol, 1997, 108:523-526. [20] 陈积愫,郑敏.寻常型银屑病患者血管内皮生长因子及单核细胞趋化因子-1表达的研究.中华皮肤科杂志,2002,35:111-113. 通讯作者: